Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon Post published:November 13, 2020 Post category:Press Release
Mind Cure Announces Non-Brokered Private Placement of $3 Million Post published:November 13, 2020 Post category:Press Release
European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives Post published:November 12, 2020 Post category:Press Release
Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer Post published:November 12, 2020 Post category:Press Release
Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange Post published:November 12, 2020 Post category:Press Release
Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications Post published:November 12, 2020 Post category:Press Release
COMPASS Pathways plc announces financial results for third quarter 2020 Post published:November 12, 2020 Post category:Press Release
NeonMind Obtains Health Canada Approval to Advance Psilocybin Research Post published:November 12, 2020 Post category:Press Release
Havn Life Announces Launch of a Range of Natural Health Products Post published:November 11, 2020 Post category:Press Release
Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin Post published:November 11, 2020 Post category:Press Release